FOXO:NYE-FOXO Technologies Inc. (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 0.2755

Change

-0.01 (-1.96)%

Market Cap

N/A

Volume

0.77M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

-0.20 (-0.30%)

USD 10.78B
DOCS Doximity Inc

+0.35 (+0.61%)

USD 10.37B
WEAV Weave Communications Inc

+0.07 (+0.43%)

USD 1.13B
AMWL American Well Corp

-0.43 (-5.46%)

USD 0.15B
MPLN MultiPlan Corporation

+0.26 (+4.32%)

USD 0.12B
OWLT Owlet Inc

N/A

USD 0.08B
ICCT iCoreConnect Inc. Common stock

+2.68 (+2,248.15%)

USD 2.90M
PHR Phreesia Inc

+0.22 (+0.87%)

N/A
VEEV Veeva Systems Inc Class A

+0.74 (+0.33%)

N/A
EVH Evolent Health Inc

-0.09 (-0.79%)

N/A

ETFs Containing FOXO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -13.83% 55% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.83% 55% F 15% F
Trailing 12 Months  
Capital Gain 3.57% 64% D 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.57% 64% D 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -7.12% 50% F 8% B-
Dividend Return -7.12% 50% F 7% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 237.22% 30% F 4% F
Risk Adjusted Return -3.00% 50% F 19% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector